FUNCTIONAL GENOMICS & DRUG DISCOVERY:
STRATEGIC APPROACHES FOR DECISION MAKINGWhen: June 4 - 5, 2018
Where: Harvard Medical School Campus, Boston, MA
What: 2-day program for science and business leaders involved in drug development
*15% discount available for applications received prior to March 15, 2018. Group discounts also available.
There has been increasing interest and investment in applying genomics and related technologies to drug discovery and development. However, with the exception of a small number of well-known successes, much uncertainty remains about how to best leverage these tools throughout the pharmaceutical value chain.
A Unique Opportunity
Led by renowned leaders from industry and academia, this program provides a unique opportunity to delve into the use of genomics in rare and complex diseases, and throughout the drug discovery, development, regulatory, and post-regulatory phases. Pre-work, case-based teaching, and project work will ground insights in real-world applications.
By the end of the program, participants will be able to:
employ new approaches for leveraging genomic tools to validate targets, streamline clinical trials, decrease late development attrition, and identify patient groups in the marketplace.
apply program concepts to inform decisions about R&D priorities and directions, the evaluation of internal and external opportunities, and strategic thinking.